GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AC Immune ACIU · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.44

+9.42%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 3.6m

FY2016FY2025

Net income

−CHF 70.4m

FY2016FY2025

Free cash flow

−CHF 67.0m

FY2016FY2025

Shareholders' equity

CHF 44.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 3.6mCHF 27.3mCHF 14.8mCHF 3.9mCHF 944,000CHF 15.4mCHF 110.5mCHF 7.2mCHF 20.3mCHF 23.2m
Research and developmentCHF 56.4mCHF 62.6mCHF 54.6mCHF 60.3mCHF 62.3mCHF 59.5mCHF 50.4mCHF 44.3mCHF 32.7mCHF 25.8m
Operating income−CHF 68.9m−CHF 52.4m−CHF 53.6m−CHF 70.8m−CHF 79.0m−CHF 61.8mCHF 44.5m−CHF 50.7m−CHF 22.5m−CHF 10.5m
Net income−CHF 70.4m−CHF 50.9m−CHF 54.2m−CHF 70.8m−CHF 73.0m−CHF 61.9mCHF 45.4m−CHF 51.0m−CHF 26.4m−CHF 7.1m
Diluted earnings per share-0.70-0.50-0.64-0.85-0.92-0.860.63-0.71-0.46-0.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 154.4mCHF 230.9mCHF 182.8mCHF 185.9mCHF 261.4mCHF 238.7mCHF 299.3mCHF 196.6mCHF 132.0mCHF 156.1m
Cash and short-term investmentsCHF 91.4mCHF 165.5mCHF 103.0mCHF 122.6mCHF 198.2mCHF 225.9mCHF 288.6mCHF 186.5mCHF 124.4mCHF 152.2m
Total liabilitiesCHF 109.5mCHF 118.6mCHF 22.2mCHF 16.9mCHF 29.5mCHF 23.3mCHF 26.8mCHF 18.9mCHF 15.2mCHF 13.7m
DebtCHF 4.5mCHF 5.4mCHF 3.5mCHF 2.8mCHF 2.9mCHF 2.2mCHF 2.9mCHF 551,838CHF 498,380—
Shareholders' equityCHF 44.9mCHF 112.3mCHF 160.6mCHF 169.0mCHF 232.0mCHF 215.5mCHF 272.4mCHF 177.6mCHF 116.8mCHF 142.4m
Shares outstanding101m101m84m84m79m72m72m71m57m57m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CHF 66.1mCHF 65.8m−CHF 60.4m−CHF 73.6m−CHF 65.7m−CHF 59.5mCHF 55.2m−CHF 44.1m−CHF 22.1m−CHF 5.6m
Capital spending−CHF 859,541−CHF 576,000−CHF 801,000−CHF 1.2m−CHF 2.6m−CHF 1.7m−CHF 1.9m−CHF 1.9m−CHF 1.8m−CHF 899,000
Free cash flow−CHF 67.0mCHF 65.3m−CHF 61.2m−CHF 74.8m−CHF 68.3m−CHF 61.2mCHF 53.3m−CHF 45.9m−CHF 23.9m−CHF 6.5m
Dividends paid———−CHF 7,000——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCHF 15.1mCHF 1.1mCHF 338,000CHF 939,000CHF 1.3mCHF 990,000CHF 1.1mCHF 25.5m
Operating incomeCHF 1.2m−CHF 14.8m−CHF 14.4m−CHF 16.2m−CHF 19.4m−CHF 19.4m−CHF 18.6mCHF 7.3m
Net incomeCHF 1.9m−CHF 14.8m−CHF 14.4m−CHF 15.9m−CHF 21.2m−CHF 19.0m−CHF 15.8mCHF 5.5m
Diluted earnings per share0.02-0.15-0.14-0.16-0.21-0.19-0.160.05
Cash from operations——−CHF 16.0m−CHF 18.0m−CHF 15.0m−CHF 18.0mCHF 5.0m−CHF 14.0m
Total assetsCHF 150.4mCHF 137.4mCHF 154.4mCHF 171.6mCHF 190.2mCHF 211.1mCHF 230.9mCHF 244.2m
Cash and short-term investmentsCHF 75.4mCHF 74.8mCHF 91.5mCHF 108.5mCHF 127.1mCHF 145.6mCHF 165.5mCHF 157.9m
DebtCHF 835,000CHF 825,000CHF 852,967CHF 1.0mCHF 1.0mCHF 1.0mCHF 1.0mCHF 694,000
Shareholders' equityCHF 35.2mCHF 31.5mCHF 44.9mCHF 62.4mCHF 74.7mCHF 94.8mCHF 112.3mCHF 130.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.2%-25.4%-21.3%
Operating income-0.9%2.2%—
Net income-0.1%2.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-392.6%-495.2%-585.7%-152.9%
Net margin-393.0%-496.5%-577.7%-150.3%

Valuation history

At each fiscal year end

FY2025
Price to earnings-4.5
Price to sales88.9

Share price return

Finished calendar years

2025
Return4%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.